| 000 | 01900 a2200637 4500 | ||
|---|---|---|---|
| 005 | 20250517165033.0 | ||
| 264 | 0 | _c20171205 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1476-5551 | ||
| 024 | 7 |
_a10.1038/leu.2017.245 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHadzijusufovic, E | |
| 245 | 0 | 0 |
_aNilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site. _h[electronic resource] |
| 260 |
_bLeukemia _c11 2017 |
||
| 300 |
_a2388-2397 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApolipoproteins E _xgenetics |
| 650 | 0 | 4 |
_aAtherosclerosis _xchemically induced |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xcytology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aPyrimidines _xadverse effects |
| 650 | 0 | 4 |
_aVascular Diseases _xchemically induced |
| 700 | 1 | _aAlbrecht-Schgoer, K | |
| 700 | 1 | _aHuber, K | |
| 700 | 1 | _aHoermann, G | |
| 700 | 1 | _aGrebien, F | |
| 700 | 1 | _aEisenwort, G | |
| 700 | 1 | _aSchgoer, W | |
| 700 | 1 | _aHerndlhofer, S | |
| 700 | 1 | _aKaun, C | |
| 700 | 1 | _aTheurl, M | |
| 700 | 1 | _aSperr, W R | |
| 700 | 1 | _aRix, U | |
| 700 | 1 | _aSadovnik, I | |
| 700 | 1 | _aJilma, B | |
| 700 | 1 | _aSchernthaner, G H | |
| 700 | 1 | _aWojta, J | |
| 700 | 1 | _aWolf, D | |
| 700 | 1 | _aSuperti-Furga, G | |
| 700 | 1 | _aKirchmair, R | |
| 700 | 1 | _aValent, P | |
| 773 | 0 |
_tLeukemia _gvol. 31 _gno. 11 _gp. 2388-2397 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/leu.2017.245 _zAvailable from publisher's website |
| 999 |
_c27416090 _d27416090 |
||